Zobrazeno 1 - 10
of 53
pro vyhledávání: '"C Arajol"'
Autor:
Climent Casals-Pascual, Jordi Guardiola, C Arajol, Alex Soriano, Begoña González-Suárez, Silvia Sala Martí, Andrea Aira, M. Angeles Domínguez
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 40:142-146
Fecal microbiota transplantation (FMT) is an effective and safe treatment to treat recurrent Clostridioides difficile infection. It is essential to make every effort to perform FMT rigorously and based on scientific knowledge. Selection of the fecal
Autor:
Andrea Aira Gómez, Sara Martí, C Arajol, Alex Soriano, Climent Casals-Pascual, Jordi Guardiola Capón, Begoña González-Suárez, M. Ángeles Domínguez Luzón
Publikováno v:
Gastroenterología y Hepatología (English Edition). 44:175-180
Faecal microbiota transplantation (FMT) is an effective and safe treatment of recurrent Clostridioides difficile infection. It is essential to make every effort to perform FMT rigorously and based on scientific knowledge. Selection of the faecal micr
Autor:
Francisco Rodríguez-Moranta, Lorena Rodríguez-Alonso, K Serra, A. Ruiz, C Arajol, Jordi Guardiola, N Padullés, Eduardo Sánchez, A Padró, R Blat, Ana Berrozpe, E Santacana, G. Suris Marin
Publikováno v:
Journal of Crohn's and Colitis. 15:S301-S302
Background HLA-DQA1*05 Carriage is associated with development of anti-drug antibodies to infliximab in patients With Crohn’s Disease (Sazonovs et al. Gastroenterology 2019). Our group has shown that the presence of this allele is also an independe
Autor:
Joan Tosca, David Busquets, Miguel Angel Marazuela Calvo, Rocío Plaza, María José Casanova, E. Domènech, Esther Rodríguez, Francesc Martínez-Cerezo, Xavier Calvet, M Rojas-Feria, Yamile Zabana, R. Atienza, Joaquín Hinojosa, Geteccu, Míriam Mañosa, Mara Charro, Fiorella Cañete, Eva Zapata, David Monfort, Guillermo Bastida, José María Huguet, Lucía Márquez, Javier P. Gisbert, Carmen Duenas, M Calafat, R de Francisco, J M Vázquez, P. Huelin, Eduard Cabré, C Arajol, Luis Fernández-Salazar, C. Garcia, Daniel Hervías, María Gómez-García, M Barreiro-de-Acosta
Publikováno v:
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Background: Onset during old age has been reported in upto 10% of total cases of inflammatory bowel disease (IBD). Aim: To evaluate phenotypic characteristics and the use of therapeutic resources in patients with elderly onset IBD. Methods: Case-cont
Autor:
R de Francisco, M Mañosa, O. García‐Bosch, Xavier Calvet, E Sainz, M Piqueras, Jordi Gordillo, C Arajol, E. Domènech, P Delgado-Villena, E Sesé, A J Lucendo, David Busquets, Beatriz Sicilia, R. Mena, Javier P. Gisbert, Fernando Gomollón, M. Rivero, L. Sanromán, Matilde Navarro, M Aceituno, Alicia Algaba, María Chaparro, Miguel Minguez, R Ferreiro-Iglesias, L de Castro, Y Zabana Abdo, A Rodríguez-Pescador, Lucía Márquez, Maite Arroyo, R. Pajares, O. Benítez, E. Iglesias, Jordina Llaó, F Murciano, M Francisco, I Rodríguez-Lago, Morales, L Arias-García, Albert Villoria, Sabino Riestra, Maria Esteve, Teresa Angueira, Jordi Guardiola, M. García, Belén Beltrán, R. Vicente, Pablo Navarro
Publikováno v:
Journal of Crohn's and Colitis. 14:S614-S615
Background INFEII registry (ClinicalTrials.gov: NCT02904590) is a prospective study promoted by GETECCU to determine the incidence and risk factors of infection in an inception cohort of IBD patients. Despite preventive measures and recommendations o
Autor:
José Manuel Benítez, Míriam Mañosa, B Velayos, Alba Juan Juan, Ignacio Alfaro, Javier P. Gisbert, Beatriz Sicilia, C Arajol, Miguel Minguez, Y Zabana, Eneida registry by Geteccu, E. Domènech, Francisco Mesonero, Albert Villoria, M. Chaparro
Publikováno v:
The American journal of gastroenterology. 114(5)
Immunosuppressant therapies (IMTs; thiopurines, anti-tumor necrosis factor agents) may influence the immunologic control of cancer and might facilitate the spread and recurrence of cancer. This study assesses the impact of the use of IMTs on the deve
Autor:
J Guardiola Capón, A Padró, Francisco Rodríguez-Moranta, N Padullés, K Serra, Blau Camps, J Orobitg, E Santacana, C Arajol, Alexandra Ruiz-Cerulla, G Surís, Lorena Rodríguez-Alonso
Publikováno v:
Journal of Crohn's and Colitis. 14:S574-S574
Background Loss of response (LOR) to tumour necrosis factor antagonists (anti-TNF) occurs in up to 50% of patients with inflammatory bowel disease (IBD). The ability to predict which patients are likely to lose response would allow therapies to be ta
Autor:
N Padullés, J Guardiola Capón, Lorena Rodríguez-Alonso, E Sanchez, K Serra, E Santacana, G Surís, Blau Camps, Francisco Rodríguez-Moranta, C Arajol, Alexandra Ruiz-Cerulla
Publikováno v:
Journal of Crohn's and Colitis. 14:S532-S532
Background AntiTNF therapeutic drug monitoring is currently performed at trough, immediately before drug administration. However, in clinical practice when subcutaneous medications are used, blood extractions often do not coincide with that moment. T
Autor:
L. Rodriguez Alonso, A Padró, J Orobitg, G Ibáñez-Sanz, K Serra, Blau Camps, L de la Peña, F. Rodriguez Moranta, Pau Gilabert, Ana Berrozpe, C Arajol, Alexandra Ruiz-Cerulla, E Santacana, A Serracarbasa, Jordi Guardiola, N Padullés
Publikováno v:
Journal of Crohn's and Colitis. 13:S435-S436
Autor:
Gemma Binefa, Alexandra Ruiz-Cerulla, Triana Lobatón, Jordi Guardiola, Francisco Rodríguez-Moranta, Victor Moreno, C Arajol, Lorena Rodríguez-Alonso
Publikováno v:
Digestive and Liver Disease. 47:797-804
European health systems have developed referral guidelines for the selection of patients for the urgent investigation of suspected colorectal cancer.To evaluate whether quantitative faecal immunochemical testing performs better than commonly used hig